Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer: Will Earnings Beat Get the Shares Moving?
Seeking Alpha
Tuesday, August 3, 2010 - 10:13am
tags:
Pfizer, earnings
Trius Therapeutics prices shares of downsized IPO
CNBC
Tuesday, August 3, 2010 - 9:59am
tags:
IPOs, Trius Therapeutics
Adult stem cell therapies making rapid progress in human studies
Fierce Biotech Research
Tuesday, August 3, 2010 - 9:58am
tags:
stem cells, Geron
Diabetes drugs dispensed by NHS rockets 43% in five years
Pharma Times, UK
Tuesday, August 3, 2010 - 9:56am
tags:
UK, diabetes
Advisors tell Alcon shareholders to vote 'no' to Novartis slate
Pharma Times, UK
Tuesday, August 3, 2010 - 9:55am
tags:
Alcon, M&A, Novartis
Geron Posts Narrower Loss
Yahoo/Zacks.com
Tuesday, August 3, 2010 - 9:54am
tags:
Geron, earnings
Rigel posts 2Q net income on AstraZeneca payment
Yahoo/AP
Tuesday, August 3, 2010 - 9:53am
tags:
AstraZeneca, Rigel, earnings
Allergan CEO Says Company Isn't For Sale, Deal Would Be Tough
NASDAQ.com
Tuesday, August 3, 2010 - 8:52am
tags:
Allergan, Pharma CEOs, M&A, David Pyott
Neurocrine Biosciences is in outstanding position to build shareholder value
Yahoo/Zacks.com
Tuesday, August 3, 2010 - 8:49am
tags:
Neurocrine
Pfizer Wallops Profit, Sales Estimates
TheStreet.com
Tuesday, August 3, 2010 - 8:25am
tags:
Pfizer, earnings
Sanofi sends $69/share offer to Genzyme: sources
Yahoo/Reuters
Tuesday, August 3, 2010 - 8:22am
tags:
M&A, Sanofi, Genzyme, GSK, JNJ
Where Does the WuXi Deal Breakup Leave Charles River?
Seeking Alpha
Tuesday, August 3, 2010 - 8:19am
tags:
Charles River Laboratories, M&A, WuXi PharmaTech
Jazz Pharma - FDA Panel Prep
TheStreet.com
Tuesday, August 3, 2010 - 8:17am
tags:
FDA, advisory panels, Jazz Pharmaceuticals, fibromyalgia, JZP-6
Allergan's Botox Migraine Review Extended Three Months by U.S. Regulators
Bloomberg
Monday, August 2, 2010 - 8:34pm
tags:
Allergan, FDA, migraines, Botox
What Investors Think About Alexion Pharmaceuticals
Motley Fool
Monday, August 2, 2010 - 8:31pm
tags:
Alexion
Momenta cuts loss
Bizjournals.com
Monday, August 2, 2010 - 8:17pm
tags:
earnings, Momenta
Merck, Stallergenes race to FDA with new allergy treatments
Fierce Biotech
Monday, August 2, 2010 - 8:15pm
tags:
Merck, Stallergenes, FDA, allergies, Grazax, Oralair, sublingual treatments
Can Roche Handle the Truth? “A Few Good Men” Case Could Expose Acne Drug Dangers
BNET Pharma
Monday, August 2, 2010 - 8:12pm
tags:
Roche, Accutane
Sanofi-Aventis in acquisition talks with Genzyme: WSJ
Marketwatch
Monday, August 2, 2010 - 8:09pm
tags:
Genzyme, M&A, Sanofi
Cardioxyl gets $15M and positive data on lead program
Fierce Biotech
Monday, August 2, 2010 - 10:41am
tags:
Cardioxyl, clinical trials, funding

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.